- In May 2024, ProPharma announced the development of the Cell Manufacturing Box (CF Box) in collaboration with PBL. This enclosed, fully automated cell manufacturing equipment enables decentralized production of various Cell & Gene Therapies (CAGT) in Class D (ISO8) or c.n.c. adjacent environments, representing a significant advancement in cell therapy manufacturing technology
- In January 2024, Thermo Fisher Scientific introduced the Gibco™ Cell Therapy Systems (CTS™) Cellmation Software, an innovative automation solution designed to integrate workflows across multiple Thermo Fisher cell therapy instruments while ensuring cGMP compliance, aimed at optimizing clinical manufacturing processes for developers of breakthrough cell therapies
- In May 2024, SINFONIA TECHNOLOGY CO., LTD. announced the delivery of two units of its CellQualia Intelligent Cell Processing (ICP) System to Keio University. These systems were delivered in March and completed their Performance Qualification in April of the same year. The devices are set to support the stable production and supply of high-quality cell medicines, crucial for advancing regenerative medicine, a promising next-generation medical treatment
- In October 2023, Molecular Devices, LLC., a prominent provider of high-performance solutions in life sciences and an operating entity within Danaher Corporation's (NYSE: DHR) life sciences segment, introduced the patent-pending CellXpress.ai Automated Cell Culture System. This innovative solution integrates an incubator, liquid handler, and imager, enhanced with machine-learning capabilities
